4//SEC Filing
Kite Pharma, Inc. 4
Accession 0001209191-16-121339
CIK 0001510580operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:08 PM ET
Size
5.5 KB
Accession
0001209191-16-121339
Insider Transaction Report
Form 4
JENKINSON PAUL L
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-05-16+125,000→ 125,000 totalExercise: $45.04Exp: 2026-05-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on the first anniversary of the grant date identified in column 3, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
Kite Pharma, Inc.
CIK 0001510580
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001510580
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:08 PM ET
- Size
- 5.5 KB